actinomycin-D

This page contains recent news articles, when available, and an overview of actinomycin-D but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Spectrum Pharmaceuticals Presents Data on Lucanthone, a Novel ...  -  Apr 17, 2008
Lucanthone has structural and biochemical similarities to Actinomycin D but has no hematological or GI toxicity at clinically tolerated doses. Business Wire (press release),

Retrospective analysis of 105 cases with uterine sarcoma  -  Apr 5, 2008
Despite two other trials reporting better survival rates with a vincristine, actinomycin-D and cyclophosphamide (VAC) regimen, there exist trials reporting Bulletin du Cancer (Abonnement),

Vanishing Bone Disease: Review and Case Reports  -  10 Mar 2008
Therapeutic treatment with estrogens, magnesium, calcium, vitamin D and vitamin B12, fluoride, and calcitonin as well as cisplatin, actinomycin D, Ortho SuperSite,

[an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] :

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.